ArticleSage open pediatrics
Solid-Pseudo papillary Tumor of the Pancreas (Frantz Tumor): Case Report of a Rare Pancreatic Tumor in Ethiopia.
Article in Sage open pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solid-pseudopapillary tumor (SPT) of the pancreas is an extremely rare neoplasm in children, with an unknown origin. It accounts for 8% to 12% of primary pancreatic tumors and predominantly affects young females (91%), with very few cases reported in males. Malignant potential is minimal, particularly in adolescents. We report a 12-year-old child presenting with abdominal distension, nausea, vomiting, appetite loss, weight loss, pruritus, jaundice, dark urine, and back pain. Examination revealed a distended abdomen moving with respiration and a firm, tender 15 cm × 20 cm mass in the right upper quadrant. CT imaging demonstrated a large heterogeneously enhancing mass arising from the pancreatic head, consistent with SPT. Surgical therapy remains the treatment of choice, with partial duodenopancreatectomy or distal pancreatectomy (spleen-preserving when possible) recommended for complete excision. Although the body and tail are more commonly affected, complete resection (R0) offers excellent prognosis, even with local invasion or metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.